• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙升高促进α-突触核蛋白聚集物的形成。

Raised calcium promotes α-synuclein aggregate formation.

机构信息

Biomolecular Dynamics, Katholieke Universiteit Leuven, Leuven, Belgium.

出版信息

Mol Cell Neurosci. 2011 Feb;46(2):516-26. doi: 10.1016/j.mcn.2010.12.004. Epub 2010 Dec 9.

DOI:10.1016/j.mcn.2010.12.004
PMID:21145971
Abstract

Parkinson's and Parkinson's-plus diseases are associated with abnormal, aggregated forms of the protein, α-synuclein. We have investigated the effects of calcium on α-synuclein aggregation in vitro and in vivo. We treated monomeric α-synuclein with calcium in vitro and used fluorescence imaging, fluorescence correlation and scanning electron microscopy to investigate protein aggregation. Incubation of fluorescent-labelled monomeric α-synuclein (24h) at low concentration (10 μM) with calcium resulted in surface aggregates (1.5±0.7 μm(2)) detected by fluorescence microscopy saturating at a half-maximum calcium concentration of 80 μM, whilst incubations without calcium showed few protein aggregates. Scanning electron microscopy revealed that α-synuclein surface plaques (0.5-1 μm) form in the presence of calcium and comprise 10-20 nm globular particles. Incubation of α-synuclein at high concentration (75 μM; 6h) resulted in soluble oligomeric aggregates detected by fluorescence correlation spectroscopy in a calcium dependent process, saturating at a half maximum calcium concentration of 180 μM. In cell culture experiments, we used thapsigargin or calcium ionophore A23187 to induce transient increases of intracellular free calcium in human 1321N1 cells expressing an α-synuclein-GFP construct and observed calcium flux and α-synuclein aggregation by fluorescence microscopy. The cell culture data shows that a transient increase in intracellular free calcium significantly increased the proportion of cells bearing cytoplasmic α-synuclein aggregates 6 and 12h post-treatment (P, 0.01). Our data indicates that calcium accelerates α-synuclein aggregation on surfaces, in free solution and in cultured cells and suggests that surface adsorption may play an important role in the calcium-dependent aggregation mechanism.

摘要

帕金森病和帕金森病综合征与蛋白质α-突触核蛋白的异常聚集形式有关。我们研究了钙对α-突触核蛋白在体外和体内聚集的影响。我们在体外用钙处理单体α-突触核蛋白,并使用荧光成像、荧光相关和扫描电子显微镜来研究蛋白质聚集。用荧光标记的单体α-突触核蛋白(孵育 24 小时)在低浓度(10 μM)下与钙孵育,导致通过荧光显微镜检测到表面聚集物(1.5±0.7 μm²),半最大钙浓度为 80 μM 时达到饱和,而没有钙孵育的情况下,很少有蛋白质聚集。扫描电子显微镜显示,α-突触核蛋白表面斑块(0.5-1 μm)在钙存在的情况下形成,包含 10-20 nm 的球形颗粒。在高浓度(75 μM;孵育 6 小时)下孵育α-突触核蛋白会导致通过荧光相关光谱检测到可溶性寡聚体聚集物,这是一个依赖于钙的过程,半最大钙浓度为 180 μM 时达到饱和。在细胞培养实验中,我们使用他莫昔芬或钙离子载体 A23187 诱导表达α-突触核蛋白-GFP 构建体的人 1321N1 细胞内细胞内游离钙的短暂增加,并通过荧光显微镜观察钙流和α-突触核蛋白聚集。细胞培养数据表明,细胞内游离钙的短暂增加显著增加了处理后 6 和 12 小时携带细胞质α-突触核蛋白聚集物的细胞比例(P,0.01)。我们的数据表明,钙加速了α-突触核蛋白在表面、游离溶液和培养细胞中的聚集,并表明表面吸附可能在钙依赖性聚集机制中起重要作用。

相似文献

1
Raised calcium promotes α-synuclein aggregate formation.钙升高促进α-突触核蛋白聚集物的形成。
Mol Cell Neurosci. 2011 Feb;46(2):516-26. doi: 10.1016/j.mcn.2010.12.004. Epub 2010 Dec 9.
2
Raised calcium and oxidative stress cooperatively promote alpha-synuclein aggregate formation.钙升高和氧化应激协同促进α-突触核蛋白聚集形成。
Neurochem Int. 2013 Apr;62(5):703-11. doi: 10.1016/j.neuint.2012.11.004. Epub 2012 Nov 15.
3
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.在帕金森病早期,α-突触核蛋白重新分布至黑质中的神经黑素脂质。
Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6.
4
Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity.铜结合调节细胞内α-突触核蛋白的定位、聚集和毒性。
J Neurochem. 2010 May;113(3):704-14. doi: 10.1111/j.1471-4159.2010.06638.x. Epub 2010 Feb 5.
5
Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.多巴胺促进人神经母细胞瘤 SH-SY5Y 细胞中α-突触核蛋白寡聚化。
Biochem Biophys Res Commun. 2010 Jan 1;391(1):129-34. doi: 10.1016/j.bbrc.2009.11.015. Epub 2009 Nov 11.
6
Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.在帕金森病大鼠模型中,磷酸化既不会促使也不会阻止α-突触核蛋白毒性物质的形成。
Hum Mol Genet. 2009 Mar 1;18(5):872-87. doi: 10.1093/hmg/ddn417. Epub 2008 Dec 12.
7
Mathematical approach to understand the kinetics of alpha-synuclein aggregation: relevance to Parkinson's disease.理解α-突触核蛋白聚集动力学的数学方法:与帕金森病的相关性。
Comput Biol Med. 2008 Oct;38(10):1084-93. doi: 10.1016/j.compbiomed.2008.08.008. Epub 2008 Sep 26.
8
[The wild-type alpha-synuclein over-expression to induce the protein aberrant aggregation of alpha-synuclein in HEK293 cells in vitro].[野生型α-突触核蛋白过表达以在体外诱导HEK293细胞中α-突触核蛋白的蛋白质异常聚集]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Feb;23(1):19-22.
9
Controlling the mass action of alpha-synuclein in Parkinson's disease.控制帕金森病中α-突触核蛋白的质量作用
J Neurochem. 2008 Oct;107(2):303-16. doi: 10.1111/j.1471-4159.2008.05612.x. Epub 2008 Sep 2.
10
Selective detection, quantification, and subcellular location of alpha-synuclein aggregates with a protein aggregate filtration assay.通过蛋白质聚集体过滤分析对α-突触核蛋白聚集体进行选择性检测、定量和亚细胞定位。
Biotechniques. 2008 Mar;44(3):403-11. doi: 10.2144/000112691.

引用本文的文献

1
Role of Cellular Senescence in Parkinson's Disease: Potential for Disease-Modification Through Senotherapy.细胞衰老在帕金森病中的作用:通过衰老疗法进行疾病修饰的潜力。
Biomedicines. 2025 Jun 7;13(6):1400. doi: 10.3390/biomedicines13061400.
2
LRRK2-mediated mitochondrial dysfunction in Parkinson's disease.帕金森病中由LRRK2介导的线粒体功能障碍
Biochem J. 2025 May 28;482(11):BCJ20253062. doi: 10.1042/BCJ20253062.
3
Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms.法舒地尔通过ROCK抑制介导的机制抑制α-突触核蛋白聚集。
Neurotherapeutics. 2025 Mar;22(2):e00544. doi: 10.1016/j.neurot.2025.e00544. Epub 2025 Feb 5.
4
Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions.α-突触核蛋白病中α-突触核蛋白传播的新兴靶点:机制途径与干预措施综述
Mol Neurodegener. 2025 Jan 23;20(1):10. doi: 10.1186/s13024-025-00797-1.
5
The Search for a Universal Treatment for Defined and Mixed Pathology Neurodegenerative Diseases.寻找针对特定和混合病理神经退行性疾病的通用治疗方法。
Int J Mol Sci. 2024 Dec 14;25(24):13424. doi: 10.3390/ijms252413424.
6
Synaptic sabotage: How Tau and α-Synuclein undermine synaptic health.突触破坏:tau蛋白和α-突触核蛋白如何损害突触健康。
J Cell Biol. 2025 Feb 3;224(2). doi: 10.1083/jcb.202409104. Epub 2024 Dec 24.
7
Hypoxia Pathways in Parkinson's Disease: From Pathogenesis to Therapeutic Targets.帕金森病中的缺氧途径:从发病机制到治疗靶点。
Int J Mol Sci. 2024 Sep 29;25(19):10484. doi: 10.3390/ijms251910484.
8
Calcium Deregulation in Neurodegeneration and Neuroinflammation in Parkinson's Disease: Role of Calcium-Storing Organelles and Sodium-Calcium Exchanger.钙失衡与帕金森病神经炎症和神经退行性变:钙储存细胞器和钠钙交换体的作用。
Cells. 2024 Aug 4;13(15):1301. doi: 10.3390/cells13151301.
9
Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases.神经退行性疾病中选择性脆弱性的分子和细胞机制。
Nat Rev Neurosci. 2024 May;25(5):351-371. doi: 10.1038/s41583-024-00806-0. Epub 2024 Apr 4.
10
Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit.GABA 通路在帕金森病运动和非运动症状中的作用:一个双向回路。
Eur J Med Res. 2024 Mar 27;29(1):205. doi: 10.1186/s40001-024-01779-7.